Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents and anticonvulsant drugs. Its trifluoromethylphenyl group enhances metabolic stability and lipophilicity, making it valuable in optimizing drug candidates for improved bioavailability and blood-brain barrier penetration. Commonly employed in asymmetric synthesis to introduce stereochemical control in active pharmaceutical ingredients.